Stockscreener 앱 받기
54.63
0.55%
0.30
시간 외 거래:
54.63
전일 마감가:
$54.33
열려 있는:
$54.15
하루 거래량:
1.72M
Relative Volume:
0.76
시가총액:
$8.56B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
58.12
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
-4.31%
1개월 성능:
-5.60%
6개월 성능:
-10.78%
1년 성능:
-26.69%
1일 변동 폭
$54.09
$55.25
1주일 범위
$52.93
$57.60
52주 변동 폭
$46.01
$80.95
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
(612) 379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
54.63 | 8.45B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Published on: 2025-09-01 12:30:20 - Newser
Using Ichimoku Cloud for Bio Techne Corporation technicals2025 Key Lessons & Risk Controlled Stock Alerts - Newser
What machine learning models say about Bio Techne CorporationBear Alert & Community Consensus Picks - Newser
Is Bio Techne Corporation still worth holding after the dipTrade Analysis Summary & Weekly Market Pulse Updates - Newser
Using portfolio simulators with Bio Techne Corporation includedJuly 2025 Technicals & Real-Time Volume Analysis Alerts - Newser
Chart based exit strategy for Bio Techne CorporationPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Automated trading signals detected on Bio Techne CorporationMarket Activity Report & Consistent Profit Trading Strategies - Newser
Published on: 2025-08-30 21:11:50 - Newser
Quantitative breakdown of Bio Techne Corporation recent moveTrade Entry Report & Reliable Price Action Trade Plans - Newser
Is Bio Techne Corporation a candidate for recovery playWeekly Profit Analysis & Technical Confirmation Alerts - Newser
Applying big data sentiment scoring on Bio Techne Corporation2025 Volume Leaders & Weekly Momentum Picks - Newser
Using economic indicators to assess Bio Techne Corporation potentialQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Real time alert setup for Bio Techne Corporation performance2025 Key Lessons & Breakout Confirmation Alerts - Newser
Fibonacci Retracement Aligns with Support in Bio Techne Corporation getLinesFromResByArray error: size == 0 - 클래시안
Applying chart zones and confluence areas to Bio Techne CorporationEarnings Miss & Daily Profit Focused Stock Screening - Newser
Is it time to cut losses on Bio Techne CorporationJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Tools to monitor Bio Techne Corporation recovery probabilityJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
Published on: 2025-08-28 20:41:13 - Newser
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Using Python tools to backtest Bio Techne Corporation strategiesEntry Point & Long-Term Safe Return Strategies - Newser
Bio-Techne Corp to Present at Several Upcoming Investor Conferences - AInvest
BIO-TECHNE Corp Directors Execute Share Sales - TradingView
Bio-Techne Directors Baumgartner and Nusse Buy and Sell Shares in Same Day - AInvest
Risk adjusted return profile for Bio Techne Corporation analyzedWeekly Trading Summary & AI Forecast Swing Trade Picks - Newser
Bt Brands, Inc. shares rise 6.78% intraday after Bio-Techne Corporation announced investor conference presentations. - AInvest
Leading Biotech Company Bio-Techne Set for Three Major Wall Street Healthcare Conference Presentations - Stock Titan
Applying sector rotation models to Bio Techne Corporation2025 Price Momentum & Weekly High Potential Alerts - Newser
Advanced analytics toolkit walkthrough for Bio Techne CorporationWeekly Loss Report & Precise Swing Trade Entry Alerts - Newser
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):